Answers are grounded in this paper and cite their sources.
This correction highlights improvements in phospholipase D inhibitors for lung cancer, suggesting enhanced efficacy in immunotherapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: